These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 23217279)

  • 1. Involvement of consumers in health technology assessment activities by Inahta agencies.
    Hailey D; Werkö S; Bakri R; Cameron A; Göhlen B; Myles S; Pwu J; Yothasamut J
    Int J Technol Assess Health Care; 2013 Jan; 29(1):79-83. PubMed ID: 23217279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survey on the involvement of consumers in health technology assessment programs.
    Hailey D; Nordwall M
    Int J Technol Assess Health Care; 2006; 22(4):497-9. PubMed ID: 16984683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of the International Network of Agencies for Health Technology Assessment.
    Hailey D
    Int J Technol Assess Health Care; 2009 Jul; 25 Suppl 1():24-7. PubMed ID: 19500434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EVALUATION OF PATIENT AND PUBLIC INVOLVEMENT INITIATIVES IN HEALTH TECHNOLOGY ASSESSMENT: A SURVEY OF INTERNATIONAL AGENCIES.
    Weeks L; Polisena J; Scott AM; Holtorf AP; Staniszewska S; Facey K
    Int J Technol Assess Health Care; 2017 Jan; 33(6):715-723. PubMed ID: 29122048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What's in a name? Developing definitions for common health technology assessment product types of the International Network of Agencies for Health Technology Assessment (inahta).
    Merlin T; Tamblyn D; Ellery B;
    Int J Technol Assess Health Care; 2014 Oct; 30(4):430-7. PubMed ID: 25397872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health technology assessment agencies: an international overview of organizational aspects.
    Martelli F; La Torre G; Di Ghionno E; Staniscia T; Neroni M; Cicchetti A; Von Bremen K; Ricciardi W;
    Int J Technol Assess Health Care; 2007; 23(4):414-24. PubMed ID: 17937828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The 'Top 10' Challenges for Health Technology Assessment: INAHTA Viewpoint.
    O'Rourke B; Werkö SS; Merlin T; Huang LY; Schuller T
    Int J Technol Assess Health Care; 2020; 36(1):1-4. PubMed ID: 31775943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toward transparency in health technology assessment: a checklist for HTA reports.
    Hailey D
    Int J Technol Assess Health Care; 2003; 19(1):1-7. PubMed ID: 12701934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of Evidence-Informed Deliberative Processes by Health Technology Assessment Agencies Around the Globe.
    Oortwijn W; Jansen M; Baltussen R
    Int J Health Policy Manag; 2020 Jan; 9(1):27-33. PubMed ID: 31902192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A preliminary survey on the influence of rapid health technology assessments.
    Hailey D
    Int J Technol Assess Health Care; 2009 Jul; 25(3):415-8. PubMed ID: 19619362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health technology assessment use and dissemination by patient and consumer groups: why and how?
    Fattal J; Lehoux P
    Int J Technol Assess Health Care; 2008; 24(4):473-80. PubMed ID: 18828943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An international survey of the public engagement practices of health technology assessment organizations.
    Whitty JA
    Value Health; 2013; 16(1):155-63. PubMed ID: 23337227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. INSIGHTS FROM THE FRONT LINES: A COLLECTION OF STORIES OF HTA IMPACT FROM INAHTA MEMBER AGENCIES.
    Schuller T; Söderholm Werkö S
    Int J Technol Assess Health Care; 2017 Jan; 33(4):409-410. PubMed ID: 29241477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A consumer involvement model for health technology assessment in Canada.
    Pivik J; Rode E; Ward C
    Health Policy; 2004 Aug; 69(2):253-68. PubMed ID: 15212871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Managing external risks to health technology assessment programs.
    Hailey D; Juzwishin D
    Int J Technol Assess Health Care; 2006; 22(4):429-35. PubMed ID: 16984675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Moving cautiously: Public involvement and the health technology assessment community.
    Gauvin FP; Abelson J; Giacomini M; Eyles J; Lavis JN
    Int J Technol Assess Health Care; 2011 Jan; 27(1):43-9. PubMed ID: 21262071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "It all depends": conceptualizing public involvement in the context of health technology assessment agencies.
    Gauvin FP; Abelson J; Giacomini M; Eyles J; Lavis JN
    Soc Sci Med; 2010 May; 70(10):1518-26. PubMed ID: 20207061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toward a Strategy to Involve Patients in Health Technology Assessment in Spain.
    Toledo-Chávarri A; Alvarez-Perez Y; Triñanes Y; Perestelo-Pérez L; Espallargues M; Palma M; Serrano-Aguilar P
    Int J Technol Assess Health Care; 2019 Jan; 35(2):92-98. PubMed ID: 30867077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How health technology assessment agencies address the issue of unpublished data.
    Kreis J; Panteli D; Busse R
    Int J Technol Assess Health Care; 2014 Jan; 30(1):34-43. PubMed ID: 24622603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patients, users, caregivers, and citizens' involvement in local health technology assessment unit in Quebec: a survey.
    Poder TG; Safianyk C; Fournier MF; Ganache I; Touré M; Pomey MP; Gagnon MP
    Int J Technol Assess Health Care; 2020 Sep; 37():e5. PubMed ID: 32988424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.